Non-covalent recognition of ubiquitin (Ub) and ubiquitinlike molecules (Ubls) by interacting proteins has an important role in the regulation of protein function and initiation of signalling events. In addition, growing evidence suggests that regulation of p53 subcellular localization contributes to the biological outcome of the p53 response. Cytoplasmic p53 is shown to promote apoptosis and inhibit the induction of autophagy. In this study we show that NEDD8 ultimate buster 1 (NUB1), a non-covalent interactor of the Ubl NEDD8 (neural precursor cell expressed, developmentally downregulated 8), controls the localization of p53. Expression of NUB1 leads to decreased modification of p53 with NEDD8 and stimulation of p53 ubiquitination. The biological outcome is the cytoplasmic localization and inhibition of the transcriptional activity of p53. Although the effects of NUB1 on p53 depend on NEDDylation and the murine double minute 2 (Mdm2) E3-ligase, the cooperation of NEDD8 with ubiquitin is required. The data identify a role for NEDD8 in controlling p53 localization and suggest that NEDD8 can control protein function through its non-covalent recognition by interacting proteins.
Introduction
Post-translational modification of proteins with ubiquitin (Ub) and ubiquitin-like molecules (Ubls) has emerged as a major mechanism of protein function regulation. Protein conjugation with Ub and Ubls involves: (1) their maturation by proteases, (2) activation by an E1 activating enzyme, (3) their transfer to an E2-conjugating enzyme and (4) covalent modification, usually on a lysine residue, on the substrate through the action of E3 ligases. The biological outcome of these modifications is very diverse, from protein destruction to regulation of transcriptional activity, subcellular localization, DNA repair, endocytosis, signal transduction and autophagy (Welchman et al., 2005; Kerscher et al., 2006) . It is now evident that Ub and Ubls upon their conjugation on substrates are recognized by a set of proteins. Therefore, they serve as scaffolds for protein-protein interactions, initiating cascades of signalling events. This has been shown for Ub and small ubiquitin-related modifier (SUMO) interacting proteins, which contain binding domains/motifs, the socalled ubiquitin-binding domains and SUMO-interacting motifs (Hicke et al., 2005; Hurley et al., 2006; Kirkin and Dikic, 2007) . It is therefore possible that this mode of action and signal transduction exists for other Ubls. The NEDD8 (neural precursor cell expressed, developmentally downregulated 8) Ubl has a well-established role in the regulation of protein ubiquitination, through modification of cullins and it is also involved in the regulation of transcriptional activity and membrane receptor signalling (Rabut and Peter, 2008; Xirodimas, 2008) . There is no NEDD8 recognition motif characterized, but binding partners have been identified. In a yeast two-hybrid screen using NEDD8 as bait, the NUB1 (NEDD8 Ultimate Buster 1) protein was identified as a binding partner. NUB1 is an interferoninducible protein and possesses a UBL (ubiquitin-like) domain at the N-terminal region and two ubiquitinassociated domains at the C-terminus Kito et al., 2001) . Interestingly, the NUB1 splice variant NUBL1, which contains an extra ubiquitinassociated domain was shown to interact with the FAT10 Ubl (Hipp et al., 2004; Schmidtke et al., 2006) . Expression of NUB1 was shown to decrease the levels of free unconjugated NEDD8 and of NEDDylated proteins. This reduction was completely blocked by 26S proteasome inhibitors Kito et al., 2001) . Furthermore, NUB1 was shown to interact with S5a, a subunit of the 26S proteasome, suggesting that NUB1 may have an adaptor role, recruiting both the NEDD8 monomer and its conjugates to the 26S proteasome for degradation (Tanji et al., 2005) . However, the role of NUB1 in the regulation of the function of NEDDylated substrates remains unknown.
The p53 tumour suppressor protein is a vital regulator of cell growth, as abnormal cell proliferation is associated with either mutations or absence of the p53 gene, or defects in upstream regulators or downstream effectors in the p53 pathway. In response to stress, both the levels and activity of p53 as a transcription factor are increased, resulting in cell growth arrest, apoptosis or cellular senescence. Post-translational modifications of p53 with Ub and Ubls such as SUMO and NEDD8 are part of p53 stability and activity regulation (Vogelstein et al., 2000; Carter and Vousden, 2009; Coutts et al., 2009; Lee and Gu, 2010) . The murine double minute 2 (Mdm2) oncogene product is a major regulator of p53 function and as an E3-ligase controls p53 modification with Ub and Ubls. In particular, Mdm2 has a dual specificity for Ub and NEDD8 and can promote p53 modification with both molecules (Xirodimas et al., 2004) . Although Mdm2 can promote ubiquitination and degradation of p53 in both nucleus and cytoplasm (Xirodimas et al., 2001b) , it is suggested that the levels of Mdm2 can have a differential effect on p53 ubiquitination with distinct biological outcomes. High levels of Mdm2 can promote polyubiquitination and nuclear proteasomal degradation of p53, whereas low levels of Mdm2 promote multiple monoubiquitination resulting in p53 nuclear export and cytoplasmic localization (Boyd et al., 2000; Geyer et al., 2000; Lohrum et al., 2001; Li et al., 2003) . Mono-ubiquitinated p53 was shown to translocate to the mitochondria and it can induce apoptosis through mitochondrial outer membrane permeabilization. Direct activation of pro-apoptotic factors, such as Bax and Bak, and/or inhibition of antiapoptotic proteins, such as Bcl2 and BclXl, are proposed mechanisms for the induction of apoptosis by cytoplasmic p53 (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004; Speidel et al., 2006; Marchenko et al., 2007) . Recently, cytoplasmic p53 was shown to inhibit the induction of autophagy (Tasdemir et al., 2008; Green and Kroemer, 2009) . Interestingly, even when the above functions do not require p53-dependent transcription, activation of p53 target genes seems to influence the outcome of the cytoplasmic p53 response. The product of the p53-induced gene PUMA (p53-upregulated modulator of apoptosis), has been reported to cooperate with cytoplasmic p53 in the induction of apoptosis (Chipuk et al., 2005) .In contrast, p53 induces the expression of DRAM (damage-regulated autophagy modulator) and sestrin 2, which facilitate the induction of autophagy (Crighton et al., 2006; Budanov and Karin, 2008; Maiuri et al., 2009) . Therefore, cytoplasmic p53, through coordination with nuclear p53 functions, contributes in the execution of the p53 response. Elucidation of the pathways that control p53 localization will provide insights in the mechanisms that control the cytoplasmic functions of p53 and possibly identify novel roles for p53 in the cytoplasm.
We found that NUB1 differentially controls p53 modification with NEDD8 and ubiquitin and promotes p53 localization in the cytoplasm. NUB1 decreases p53 NEDDylation and it promotes p53 ubiquitination. These effects of NUB1 require Mdm2, which promotes p53 modification with NEDD8 and ubiquitin. Although the role of NUB1 on p53 modification and localization also depend on NEDD8 conjugation, the cooperation of the NEDD8 and ubiquitin pathways is required for NUB1 to elicit its effects on p53. These studies identify a role for NEDD8 in controlling p53 localization and suggest that NEDD8 can control protein function through its noncovalent recognition by interacting proteins.
Results
NUB1 differentially controls p53 NEDDylation/ ubiquitination NUB1 was isolated in a yeast two-hybrid screen using NEDD8 as bait, indicating that NUB1 interacts with NEDD8 in vivo. To verify the direct non-covalent interaction of NUB1 with NEDD8, recombinant His 6 -GST-NUB1 was incubated with either recombinant NEDD8 or ubiquitin. As shown in Figure 1a , His 6 -GST-NUB1 interacted with NEDD8 but not with ubiquitin, validating the direct non-covalent interaction between NUB1 and NEDD8. We then analysed the effect of NUB1 on NEDDylation in vivo. H1299 cells were transfected with His 6 -NEDD8 either in the presence or absence of NUB1. The effect of NUB1 on ubiquitination was also monitored. Consistent with previous studies, expression of NUB1 resulted in a dramatic decrease in NEDDylation . Under similar conditions general ubiquitination was not affected (Figure 1b) . The Mdm2 E3 ligase has a dual activity and can promote modification of p53 with both NEDD8 and ubiquitin (Xirodimas et al., 2004) . We tested the effects of NUB1 on Mdm2-mediated modification of p53 with NEDD8 and ubiquitin in H1299 cells. Although NUB1 caused a decrease in p53 NEDDylation, surprisingly, p53 ubiquitination was significantly enhanced (Figure 1c ). The effect of NUB1 is specific for these post-translational modifications, as SUMO-2 conjugation of p53 was not affected by NUB1.
NUB1 controls general and p53 NEDDylation at endogenous levels
The data show that overexpression of NUB1 causes a decrease in general and p53 NEDDylation. To examine the role of NUB1 on NEDDylation at endogenous expression levels, we generated stably transformed MCF7 cells, which have wild-type p53, expressing His 6 -NEDD8 (MCF7-ND8). In this system, the level of expression of His 6 -NEDD8 is comparable to the endogenous NEDD8 (Figure 2a, see quantitation) . This system allows the efficient isolation of endogenous proteins modified with NEDD8, as cell lysis and purification is performed under denaturing conditions, preventing deconjugation through the action of proteases. MCF7-ND8 cells were transfected with either control or NUB1 small interfering RNAs (siRNAs) and treated as indicated with the proteasome inhibitor MG132. As shown in Figure 2b , knocking down endogenous NUB1 caused an increase in general NEDDylation. Furthermore, reducing endogenous NUB1 levels also increased endogenous p53 NEDDylation (Figure 2c ). These data suggest that NUB1 is a physiological regulator of protein NEDDylation.
NUB1 promotes formation of fast-migrating ubiquitinated forms of p53
The increase in p53 ubiquitination, which was detected in the presence of NUB1 in Figure 1c , is restricted to a relatively small number of conjugated ubiquitin NUB1 promotes cytoplasmic localization of p53 G Liu and DP Xirodimas molecules, suggesting that NUB1 prevents efficient p53 poly-ubiquitination. We used two approaches to test this hypothesis. We compared the effects of NUB1 on p53 ubiquitination using either wild-type ubiquitin or the K0 mutant, which has all the lysines mutated into arginines, preventing the formation of ubiquitin chains through lysine modification. Therefore, the ubiquitination profile provided by the K0 mutant most likely represents mono or multiple mono p53 ubiquitination (assigned as Low(Ub) n -p53; Figure 3a ). Slower migrating ubiquitinated forms of p53 represent ubiquitin chains (assigned as High(Ub) n -p53; Figure 3a) . Expression of NUB1 with wild-type ubiquitin resulted in an increase in the lower ubiquitinated forms of p53, whereas it reduced the higher forms (Figure 3a , see quantitation). NUB1 expression in the presence of the K0 mutant had no significant effect on p53 ubiquitination (Figure 3a , see quantitation). Furthermore, we used the proteasome inhibitor MG132 to block p53 proteasomal degradation and enrich the higher ubiquitinated forms of p53 ( Figure 3b , lanes 3 and 5, see quantitation). Expression of NUB1 increased the abundance of the lower ubiquitinated forms of p53 and decreased the higher forms (Figure 3b , quantitation). The combination of the above data suggests that the increase in p53 ubiquitination observed by NUB1 expression most likely represents p53 multiple mono-ubiquitination.
NEDDylation is required for NUB1 effect on p53 ubiquitination Our data show that NUB1 can differentially control p53 modification with NEDD8 and ubiquitin. To assess a possible link between these two phenomena, we used the SENP8/NEDP1/DEN1 protease, which can specifically remove NEDD8 from p53 but has no effect on p53 ubiquitination (Xirodimas et al., 2004) . We tested the effect of NUB1 on p53 ubiquitination in the presence of NEDP1 ( Figure 3c ). As shown before, expression of NUB1 increased p53 ubiquitination. However, in the presence of the NEDP1 protease the effect of NUB1 was completely abolished. Expression of NEDP1 alone had no effect on p53 ubiquitination. This suggests that NEDDylation is a prerequisite for NUB1 to induce p53 ubiquitination.
NUB1 interacts with p53 in vivo in a NEDD8-dependent manner The experiments described in Figure 2 show that NUB1 is a physiological regulator of p53 NEDDylation. To determine whether NUB1 interacts with p53 in vivo, we performed immunoprecipitations (IPs) in extracts from MCF7 cells, which express NUB1 and wild-type p53. NUB1 was detected specifically in p53 immunoprecipitates but not in the control anti-Flag IP, suggesting that NUB1 and p53 can interact under endogenous physiological conditions (Figure 4a ). We also tested the NUB1-p53 interaction under overexpression conditions. H1299 cells were co-transfected with p53, Mdm2 and Flag-NUB1 and IPs were performed with anti-Flag antibody. Elutes were analysed by western blotting using a polyclonal anti-p53 antibody. p53 was detected only when p53 and NUB1 were coexpressed, but not in the lanes in which NUB1 was absent, suggesting that p53 interacts with NUB1 ( Figure 4b ). To assess whether NEDDylation is also important for the interaction between NUB1 and p53, the NEDP1 protease was used. NEDP1 significantly reduced the NUB1-p53 interaction but only in the presence of Mdm2 (Figure 4c ). This is (a) Recombinant His 6 -GST-NUB1 or His 6 -GST were incubated with recombinant NEDD8 (ND8) or ubiquitin (Ub). Input (5%) and GST pulldowns were analysed using western blotting with anti-NEDD8, anti-ubiquitin or anti-GST antibodies. (b) H1299 cells were transiently transfected with constructs encoding His 6 -NEDD8 (2 mg), His 6 -ubiquitin (2 mg) and Flag-NUB1 (5 mg) as indicated. Cell lysates and Ni 2 þ pull-down eluates were analysed using western blotting with the appropriate antibodies. (c) H1299 cells were transiently transfected with constructs encoding p53, Mdm2, His 6 -ubiquitin/NEDD8/SUMO-2 (2 mg each) and Flag-NUB1 (5 mg) as indicated. Cell lysates and Ni 2 þ pulldown eluates were analysed using western blotting with anti-p53, anti-Flag or anti-actin antibodies.
NUB1 promotes cytoplasmic localization of p53
G Liu and DP Xirodimas possibly because Mdm2 is able to stimulate NEDDylation on p53. The experiments show that NUB1 can interact with p53 in cells and this interaction depends on NEDDylation and the Mdm2 E3 ligase.
NUB1 suppresses p53 transcriptional activity
The data show that NUB1 can interact with p53 and differentially control p53 modification with NEDD8 and ubiquitin. To analyse the role of NUB1 in p53 transcriptional activity, we used a luciferase-based reporter assay. U2OS cells with wild-type endogenous p53 and low levels of endogenous NUB1 (data not shown) were transfected with increasing amounts of NUB1 in the presence or absence of Mdm2. The PG-13-luc plasmid, in which an artificial p53 response element drives the expression of luciferase, was used to monitor p53 transcriptional activity. In the absence of Mdm2, expression of NUB1 suppressed endogenous p53 transcriptional activity but only at high levels of expression ( Figure 5a ). However, in the presence of Mdm2 (Figure 5b ), NUB1 provided a more profound suppression of p53 activity. This suggests that the effect of NUB1 on p53 activity depends on Mdm2, consistent with our observations in Figure 4 . The use of luciferase reporters containing natural p53 response elements found in different p53 regulated genes showed that NUB1 can suppress p53 activity against different p53-induced genes (Supplementary Information S1). However, the GADD45 (growth arrest and DNA damage) and the PIG3 (p53-inducible gene 3; apoptosis) reporter (MCF7-ND8) were lysed and analysed for NEDD8 expression using western blotting. In addition, 40 ng of recombinant NEDD8 was used. Quantitation of NEDD8 signals (using Image Gauge) from control MCF7 and MCF7-ND8 cells is presented in the right panel.
(b) MCF7-ND8 cells were transfected with control or NUB1 siRNAs. After 48 h, cells were untreated or treated with 30 mM MG132 for 4 hr before being collected. Cell lysates and Ni 2 þ pulldown eluates were analysed using western blotting with the appropriate antibodies. (c) Experiment performed as in (b) using parental or MCF7-ND8 cells. Endogenous NEDDylated p53 was detected with DO-1 anti-p53 antibody in Ni 2 þ pulldown eluates, whereas cell lysates were used for the detection of total levels of p53 and NUB1. Actin was used as loading control.
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NUB1 promotes cytoplasmic localization of p53
G Liu and DP Xirodimas showed an increased sensitivity to NUB1 expression (Supplementary Information S1), suggesting a preferential suppressive role for NUB1 for p53 target genes. To address the role of endogenous NUB1 on endogenous p53 activity, we performed a similar assay in MCF7 cells, which express high levels of NUB1. Knockdown of NUB1 with siRNA increased the transcriptional activity of p53 (Figure 5c ). These data show that NUB1 suppresses p53 transcriptional activity and suggest that NUB1 cooperates with Mdm2 in p53 negative regulation.
NUB1 stimulates cytoplasmic localization of ubiquitinated p53 in Mdm2-and NEDD8-dependent manner Overexpression of NUB1 stimulates ubiquitination on p53, and suppresses p53 transcriptional activity. It has been shown that Mdm2-mediated multiple monoubiquitination of p53 can promote p53 nuclear export (see Introduction). On the basis of the effect of NUB1 on p53 ubiquitination, we tested NUB1 effect on p53 localization by subcellular fractionation. H1299 cells transfected with p53, Mdm2 and NUB1 were used to prepare nuclear and cytoplasmic fractions. NUB1 induced the modification of p53 with endogenous ubiquitin only in the presence of Mdm2 (Figure 6a , input). The fractionation shows that the ubiquitinated p53 induced by NUB1 is found almost exclusively in the cytoplasm (Figure 6a ). To confirm the fractionation results, localization of p53 was monitored using immunofluorescence. As shown in Figures 6b and c, p53 was predominantly localized in the nucleus, whereas in the presence of NUB1, cytoplasmic p53 could now be observed. However, consistent with our previous observations, the effect of NUB1 on p53 localization was further increased in the presence of Mdm2. These data show that NUB1 cooperates with Mdm2 to promote p53 ubiquitination and cytoplasmic localization. To determine the role of NEDDylation in the relocalization of p53 to the cytoplasm by NUB1, the NEDP1 protease was used. NUB1 enriched for cytoplasmic p53 in the absence of NEDP1. However, coexpression of NEDP1 completely blocked this effect, suggesting that NEDDylation is required for NUB1 to promote p53 ubiquitination and cytoplasmic localization (Figure 6d ). However, expression of NEDP1 in the absence of NUB1 had no effect on p53 localization. This suggests that decrease in NEDDylation alone is not sufficient to affect p53 localization but rather the cooperation between NEDD8 and ubiquitin is required for this effect.
Discussion
Covalent modification of substrates with Ub and Ubls can elicit signalling events through their non-covalent recognition. This regulatory module is now emerging as an important mechanism in signal transduction. We show that the NEDD8 interacting protein NUB1 can control the localization and function of the p53 tumour suppressor protein. NUB1 interacts with p53 and differentially controls p53 modification, leading to a decrease in p53 NEDDylation and in stimulation of p53 ubiquitination. The biological outcome of this effect is the localization of p53 in the cytoplasm and inhibition of p53 transcriptional activity. On the basis of the initial studies, decrease in p53 NEDDylation would increase p53 transcriptional activity (Xirodimas et al., 2004; Abida et al., 2007) . However, the additional effect of NUB1 on p53 ubiquitination and cytoplasmic localization could explain the inhibition of p53 function despite decrease in NEDDylation. The data in Figure 3 show that the increase in p53 ubiquitination promoted by Luciferase reporter assays were performed by transiently transfecting PG-13-luc, and increasing amounts of NUB1 in the absence (a) or presence (b) of Mdm2 in U2OS cells. p53 transcriptional activity was measured at 24 h after transfection. b-gal was cotransfected and used to normalize the values, which are presented as percentage changes in activity. (c) MCF7 cells were transfected with control or NUB1 siRNA. Next day, cells were transiently transfected with PG-13-luc plasmid. p53 transcriptional activity was measured at 24 h after transfection. Values were normalized with b-gal as above. 10% of the cell lysates were analysed using western blotting with anti-NUB1, anti-p53 or anti-actin antibodies.
NUB1 promotes cytoplasmic localization of p53 G Liu and DP Xirodimas NUB1 is preferential for the faster migrating forms, which most likely represent multiple mono-ubiquitinated p53. A number of studies have shown that monoubiquitination of p53 can exert an effect as a nuclear export signal. The proof of principle for this role of ubiquitin was shown with a linear p53-Ub fusion, which was shown to localize in the cytoplasm. Interestingly and somewhat surprisingly, given the very close homology to ubiquitin, p53 fused to NEDD8 was shown to localize exclusively in the nucleus (Brooks and Gu, 2006; Carter et al., 2007) . The data in our study suggest that NEDD8 may have an active role in localizing p53 in the nuclear compartment, and decrease in p53 NEDDylation is part of p53 cytoplasmic localization. The use of the NEDD8-specific protease, NEDP1, suggests that NEDDylation is a requirement for NUB1 to promote p53 ubiquitination and cytoplasmic localization. However, as the NEDP1 protease itself had no effect on p53 localization, decrease in p53 NEDDylation is necessary but not sufficient to drive its cytoplasmic localization. Rather the coordinated decrease in NEDDylation and increase in ubiquitination of p53 is required for NUB1 to elicit this effect. The data show that NUB1 can interact with p53 and this interaction depends on NEDD8 conjugation. However, mutants of p53 deficient in NEDDylation (3NKR) and ubiquitination (6KR) interact with NUB1 with similar efficiency to wild-type p53 (data not shown). Whether additional p53 lysines or components in the pathway, such as Mdm2, control the binding of NUB1 to p53 is not currently clear. Indeed, the effects of NUB1 depend on Mdm2, consistent with the idea that Mdm2 as an E3 ligase can promote p53 modification with NEDD8 and ubiquitin and therefore facilitate the action of NUB1 on p53. NUB1 could promote the recruitment of deNEDDylating and de-ubiquitinating enzymes to the p53 complex, which will alter the modification status of p53. This is supported from the observation that NUB1 expression had no effect on p53 ubiquitination in the presence of the K0 ubiquitin mutant. Therefore, the increase in p53 ubiquitination by NUB1 may result through de-polymerisation of poly-ubiquitin chains.
It would be interesting to test whether this effect of NUB1 is specific for p53 or the modification of additional NEDDylated substrates are regulated in a similar manner (Rabut and Peter, 2008; Xirodimas, 2008) . Alternatively, NUB1 promotes cytoplasmic localization of p53 G Liu and DP Xirodimas differential regulation of Mdm2 as an E3 ligase for p53 ubiquitination and NEDDylation could result in a differential p53 modification. Previous studies have shown that the interaction of Ubc13 E2-conjugating enzyme with p53 results in K63-linked p53 ubiquitination, attenuating Mdm2-mediated poly-ubiquitination. Expression of Ubc13 results in p53 cytoplasmic localization and inhibition of p53 function (Laine et al., 2006) , which phenocopies the effect of NUB1. Therefore, NUB1 could alter the E2-conjugating enzyme specificity for Mdm2, leading to differential p53 ubiquitination. In addition, efficient p53 poly-ubiquitination may require NEDDylation and NUB1 by decreasing general NEDDylation restricts Mdm2 (and possibly other p53 E3 ligases) in the stimulation of multi-monoubiquitination and cytoplasmic localization of p53. Several proteins have been identified as regulators of p53 localization. The CSN5/Jab1 component of the COP9 signalosome, which possess de-NEDDylating activity, can promote p53 cytoplasmic localization. A CSN5/Jab1 mutant, which is not incorporated into the COP9 signalosome but contains the JAMM motif responsible for its de-NEDDylating activity, is sufficient to drive p53 cytoplasmic export (Oh et al., 2006) . On the basis of the effects of NUB1 on p53 modification and subcellular localization, it would be interesting to test the role of CSN5/Jab1 on p53 modification with NEDD8 and ubiquitin. Importantly, as for NUB1, the effects of CSN5/Jab1 on p53 localization are Mdm2 dependent. This suggests that Mdm2 as an E3 ligase could promote p53 conjugation with Ub and Ubls, such as NEDD8, and therefore priming p53 for recognition by Ub and Ubl interacting proteins. Indeed, Mdm2-mediated p53 ubiquitination was proposed to allow the recruitment of PIASy SUMO E3 ligase to promote p53 SUMO conjugation (Carter et al., 2007) . The p53 interacting protein Parc (p53-associated, Parkin-like cytoplasmic protein) was shown to anchor p53 in the cytoplasm. However, as for CSN5/Jab1 the effects of Parc on p53 NEDDylation are not known (Nikolaev et al. 2003) . Furthermore, the Tip60 acetyltransferase, a regulator of the Mdm2-p53 pathway, inhibits Mdm2-mediated p53 NEDDylation but has no effect on p53 ubiquitination. This was associated with the ability of Tip60 to promote relocalization of p53 to promyelocytic leukaemia bodies (Dohmesen et al., 2008) . These findings are consistent with the identified role of NEDD8 in controlling p53 localization. However, the additional regulation of p53 ubiquitination by NUB1 may provide a differential signal, which will determine the subcellular localization of p53 (subnuclear by Tip60 or cytoplasmic by NUB1). These observations, along with recent studies showing that the nucleolar localization of the L11 ribosomal protein is controlled by NEDD8 (Sundqvist et al., 2009) , support a diverse role for NEDD8 in controlling protein localization.
In summary, our data identify an active role for NEDD8 in controlling p53 localization and provide an example of cooperation between the NEDD8 and ubiquitin pathways for protein function regulation. These studies also suggest that NEDD8 conjugation can elicit signalling events through its recognition by interacting proteins, such as NUB1, and highlight the diverse mechanisms by which NEDDylation can control protein function.
Materials and methods

Plasmids
Constructs encoding p53, Mdm2, His 6 -ubiquitin, His 6 -NEDD8, NEDP1, PG-13-Luc were described previously (Xirodimas et al., 2004) . Luciferase reporter plasmids, containing p53 response elements from different p53 regulated genes, were provided by Dr Bourdon (Ninewells Hospital, University of Dundee). The His 6 -ubiquitin K0 mutant was a gift from Dr Saville (Ninewells Hospital, University of Dundee). Flag-NUB1 was a gift from Dr Kamitani (M.D. Anderson Cancer Center, the University of Texas, TX, USA). His 6 -GST-NUB1 was made by cloning the NUB1 complementary DNA as Cterminal fusion to GST in pEHISTEV vector. All sequences were confirmed using automated sequencing.
Antibodies and chemicals
In IPs, p53 was detected with SAPU sheep polyclonal antibodies (gift from Dr Bourdon). For immunofluorescence, p53 was detected with CM1 rabbit polyclonal antibodies. For other experiments, p53 was detected with DO-1 mouse monoclonal antibodies. For the detection of free and conjugated ubiquitin, a mixture of rabbit (Abcam, Cambridge, UK) and mouse (Biomol-Enzo Life Sciences (UK) Ltd., Exeter, UK) antiubiquitin antibodies were used. Rabbit anti-NUB1 antibodies His 6 -NEDD8 cloned in an lentiviral-based vector was used to generate MCF7 cells stably expressing His 6 -NEDD8 (MCF7-ND8) using 5 mg/ml of puromycin for selection.
In vitro binding assay Bacterially expressed His 6 -GST-NUB1 was purified with Ni-NTA agarose beads. A total of 10 mg of His 6 -GST or His 6 -GST-NUB1 were incubated with 2 mg recombinant NEDD8 or ubiquitin in 400 ml NP-40 buffer (150 mM NaCl, 50 mM Tris pH 8.0, 5 mM EDTA pH 8.0, 1% NP-40 and 1 mM dithiothreitol). A total of 10 ml of GST beads was added to each reaction for 1 h at 4 1C. The beads were washed 3 Â with NP-40 buffer, and 50 ml 2Â SDS loading buffer was added before boiling. Supernatants were analysed using western blotting.
Purification of proteins modified by NEDD8/ubiquitin/SUMO-2
Proteins modified with His 6 -NEDD8, His 6 -ubiquitin or His 6 -SUMO-2 were purified as described in Xirodimas et al. (2001a) and Tatham et al. (2009) . A total of 20% of the cells were used for lysis in 2 Â SDS loading buffer.
Immunoprecipitations
Cells lysis was performed with GE buffer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 25 mM NaF, 10 mM ZnCl 2 , 10% glycerol and 1% Triton X-100) containing Roche cocktail protease inhibitors on ice for 30 min before centrifugation at 4 1C for 15 min. Equal amount of total protein was incubated with the appropriate antibody overnight before addition of 20 ml of protein G beads and 1 h rotation at 4 1C. Beads were washed 3 Â with GE buffer, and 50 ml of 2 Â SDS loading buffer was added and boiled for 5 min. Eluates were then used for western blotting. For endogenous IPs, 8 Â 10 6 MCF7 cells were lysed in NP-40 buffer and extracts were incubated either with 5 mg DO-1 anti-p53 antibody or as control 5 mg of anti-Flag antibody. IPs were analysed as above.
Luciferase reporter assay U2OS cells were transfected with NUB1 and 0.5 ng of Mdm2 plasmids. MCF7 cells were transfected with control or NUB1 siRNAs and 24 h later were reseeded in 24-well plates. In all cases, 100 ng of luciferase reporter plasmids containing the artificial p53 response element PG-13 or the element from different p53-regulated genes and 20 ng b-gal were transfected. At 24 h after transfection, cells were lysed with 150 ml lysis buffer (9.2 mM KH 2 PO 4 , 90.8 mM K 2 HPO 4 , 0.2% Triton and 0.5 mM dithiothreitol). After 20-min incubation with shaking, lysates were spun at 13 000 r.p.m. for 1 min. Luciferase signals were measured on luminometer (Berthold Microlumat Plus LB96V; BERTHOLD TECHNOLOGIES, Hertfordshire, UK) by injecting luciferase assay buffer (25 mM Tris/Phosphate pH 7.8, 2 mM MgCl 2 , 1% Triton, 15% Glycerol, 1 mM ATP, 0.25 mM Luciferin (Sigma Aldrich Company Ltd.), and 1% bovine serum albumin (BSA)). b-gal activity was measured using the Galacto-Light Plus kit (TroPix, Bedford, MA, USA) according to the manufacturer's instructions. Luciferase values were normalized with b-gal.
Subcellular fractionation
The method described in Lee et al. (1994) and Sundqvist et al. (2009) was used. In brief, cell pellets were resuspended in 1 packed cell volume of Buffer A (10 mM HEPES, pH 8.0, 10 mM KCl, 1.5 mM MgCl 2 , 1mM dithiothreitol, 0.5 mM phenylmethylsulphonyl fluoride) and allowed to swell on ice for 15 min, before being lysed through a 26-gauge needle (five strokes). After centrifugation, supernatant (cytoplasmic fraction) and the pellet (nuclear fraction, lysed directly in 2 Â SDS loading buffer) were used for western blotting.
Immunofluorescence H1299 cells were seeded on round coverslips in six-well plates and transfected with calcium phosphate. After 48 h, cells were washed with warm phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde in PBS for 10 min. Cells were then permeabilized with 0.2% Triton in PBS for 10 min, washed with PBS and blocked with 5% BSA in PBS-Tween-20 for 30 min. Primary antibodies were applied for 1 h (anti-Flag 1:1000 dilution, CM1 anti-p53 1:1000 dilution, in 1% BSA in PBS-Tween-20) before incubation with secondary antibodies (1:300 dilution in 1% BSA in PBS-Tween-20, fluorescein isothiocyanate-conjugated for NUB1, or Texas Red for p53) for 1 h at room temperature in the dark. Samples were washed with 1% BSA in PBS-Tween-20, and stained with 4,6-diamidino-2-phenylindole (1:10 000 dilution in 1% BSA in PBS-Tween-20) for 5 min at room temperature in dark. Slides were washed with 1% BSA in PBS-Tween-20, mounted with Vectashield Mounting Medium (H-1000, Vector Laboratories, Burlingame, CA, USA), sealed and viewed under the microscope (DeltaVision DV3 Deconvolution Microscope, Applied Precision, Issaquah, WA, USA). The images were analysed using SoftWoRx (Applied Precision).
